+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 19Years - 70Years
All Genders
ID07661810

Comparing Patient-Controlled and Clinician-Controlled Remimazolam Sedation During Primary Hip Replacement Under Spinal Anesthesia

Led by Seoul National University Hospital · Updated on 2026-11-03

104

Participants Needed

1

Research Sites

4 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are comparing two methods of sedation using remimazolam in adults undergoing primary hip arthroplasty with spinal anesthesia. The study aims to find out if patient-controlled sedation reduces the total amount of remimazolam used compared to clinician-controlled sedation, while also looking at sedation depth, side effects, airway interventions, and satisfaction from patients and surgeons. Participants are randomly assigned to either patient-controlled sedation, where they receive an initial dose and can self-administer additional doses with a button press under set timing rules, or clinician-controlled sedation, where an initial dose is followed by a continuous infusion adjusted by the clinician based on sedation scores. The sedation period is expected to last up to six hours during anesthesia. During the study, researchers will monitor total remimazolam use, sedation depth, need for extra sedatives, adverse events, breathing issues, airway interventions, time spent in recovery, and satisfaction scores. Preoperative anxiety and recovery quality will also be assessed. The entire process, including assessments before, during, and after surgery, will provide detailed information about sedation management in this setting.

CONDITIONS

Brief Title

Patient-controlled Remimazolam Sedation Under Spinal Anesthesia

Research Team

S

Seokha Yoo, M.D., Ph.D.

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here